Were they possibly thinking of the larger biotech companies - hold down CLSN to give the big boys a better and longer shot at capturing the market.
There is a seminar in September at which CLSN is to present their results. Will that be helpful? I should think if they didn't have anything good to say they would not be on the calendar as presenters.